AVN 66.26 Decreased By ▼ -0.24 (-0.36%)
BOP 8.85 Increased By ▲ 0.05 (0.57%)
CHCC 131.61 Increased By ▲ 0.11 (0.08%)
DCL 9.30 Increased By ▲ 0.05 (0.54%)
DGKC 104.50 Increased By ▲ 0.56 (0.54%)
EFERT 61.19 Decreased By ▼ -0.41 (-0.67%)
EPCL 44.80 Increased By ▲ 0.30 (0.67%)
FCCL 20.69 Increased By ▲ 0.08 (0.39%)
FFL 14.48 Increased By ▲ 0.23 (1.61%)
HASCOL 14.20 Increased By ▲ 0.12 (0.85%)
HBL 130.50 Increased By ▲ 0.61 (0.47%)
HUBC 79.65 Increased By ▲ 0.02 (0.03%)
HUMNL 7.11 Increased By ▲ 0.51 (7.73%)
JSCL 23.60 Increased By ▲ 0.50 (2.16%)
KAPCO 28.43 Increased By ▲ 0.23 (0.82%)
KEL 3.74 Increased By ▲ 0.03 (0.81%)
LOTCHEM 12.65 Decreased By ▼ -0.08 (-0.63%)
MLCF 39.15 Increased By ▲ 0.96 (2.51%)
OGDC 99.82 Decreased By ▼ -3.25 (-3.15%)
PAEL 32.92 Increased By ▲ 0.62 (1.92%)
PIBTL 12.36 Increased By ▲ 0.24 (1.98%)
PIOC 90.67 Increased By ▲ 0.38 (0.42%)
POWER 9.64 Increased By ▲ 0.16 (1.69%)
PPL 90.80 Decreased By ▼ -2.42 (-2.6%)
PSO 192.76 Decreased By ▼ -2.31 (-1.18%)
SNGP 42.79 Decreased By ▼ -0.39 (-0.9%)
STPL 13.55 Increased By ▲ 0.13 (0.97%)
TRG 57.73 Increased By ▲ 0.35 (0.61%)
UNITY 24.94 Increased By ▲ 1.56 (6.67%)
WTL 1.10 Increased By ▲ 0.08 (7.84%)
BR100 4,251 Decreased By ▼ -1.58 (-0.04%)
BR30 21,397 Decreased By ▼ -6.97 (-0.03%)
KSE100 40,942 Decreased By ▼ -88.64 (-0.22%)
KSE30 17,223 Decreased By ▼ -71.3 (-0.41%)

BEIJING: Nearly a million people have taken an experimental coronavirus vaccine developed by Chinese company Sinopharm, the firm said, although it has not yet provided any clear clinical evidence of efficacy. China has been giving experimental Covid-19 vaccines to people including state employees, international students and essential workers heading abroad since July.

Sinopharm's chairman told media this week that nearly a million people have now received their vaccine for emergency use, though he did not provide a specific figure.

"We have not received a single report of severe adverse reaction, and only a few had some mild symptoms," Liu Jingzhen said in an interview re-published by the state-owned firm on Wednesday.

China has been bullish about the development of its vaccine for the new virus - which first emerged in the centre of the country late last year - with four vaccines now in late-stage testing. Many of the trials are taking place overseas, as China has largely brought the virus under control within its borders.